USPH RSI Chart
Last 7 days
3.7%
Last 30 days
8.8%
Last 90 days
17.0%
Trailing 12 Months
12.8%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 569.9M | 580.8M | 591.2M | 604.8M |
2022 | 514.4M | 528.1M | 541.8M | 553.1M |
2021 | 422.6M | 465.7M | 482.7M | 495.0M |
2020 | 478.5M | 435.9M | 427.6M | 423.0M |
2019 | 461.8M | 473.1M | 477.2M | 482.0M |
2018 | 424.8M | 435.7M | 445.8M | 453.9M |
2017 | 367.2M | 381.0M | 395.7M | 414.1M |
2016 | 341.0M | 348.1M | 352.4M | 356.5M |
2015 | 312.5M | 317.6M | 324.0M | 331.3M |
2014 | 271.1M | 282.4M | 294.3M | 305.1M |
2013 | 250.6M | 254.1M | 257.8M | 264.1M |
2012 | 242.0M | 245.5M | 247.9M | 249.7M |
2011 | 217.6M | 223.4M | 229.7M | 237.0M |
2010 | 0 | 204.7M | 208.0M | 211.2M |
2009 | 0 | 0 | 0 | 201.4M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 13, 2024 | trier clayton | sold | -42,800 | 107 | -400 | - |
Mar 13, 2024 | hendrickson carey p | sold | -193,103 | 107 | -1,800 | chief financial officer |
Mar 13, 2024 | binstein richard | sold | -213,100 | 106 | -2,000 | evp gen'l counsel & secretary |
Mar 13, 2024 | ham nancy | sold | -53,945 | 107 | -500 | - |
Mar 04, 2024 | kuntz edward l | sold | -260,650 | 104 | -2,500 | - |
Mar 04, 2024 | williams eric joseph | sold | -157,440 | 104 | -1,500 | co-chief operations officer |
Mar 04, 2024 | reeve graham d. | sold | -274,441 | 104 | -2,629 | coo |
Feb 26, 2024 | hendrickson carey p | acquired | - | - | 8,100 | chief financial officer |
Feb 26, 2024 | reeve graham d. | acquired | - | - | 8,100 | coo |
Feb 26, 2024 | binstein richard | acquired | - | - | 8,100 | evp gen'l counsel & secretary |
Which funds bought or sold USPH recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | reduced | -1.84 | -1,094 | 333,628 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 2.53 | 3,903,550 | 98,954,400 | -% |
Mar 04, 2024 | Northwest Bank & Trust Co | new | - | 37,256 | 37,256 | 0.03% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 90.22 | 1,940,480 | 4,023,680 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | added | 0.76 | 17,024 | 754,900 | -% |
Feb 26, 2024 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | 5,000 | 368,000 | -% |
Feb 16, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | reduced | -19.99 | -448,000 | 1,939,000 | -% |
Feb 16, 2024 | GSA CAPITAL PARTNERS LLP | new | - | 350,000 | 350,000 | 0.03% |
Feb 16, 2024 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | unchanged | - | 294 | 12,294 | -% |
Feb 15, 2024 | State of Wyoming | added | 12.06 | 10,483 | 86,527 | 0.02% |
Unveiling US Physical Therapy Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Peers (Alternatives to US Physical Therapy Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 454.6B | 371.6B | 20.31 | 1.22 | ||||
CI | 106.2B | 195.3B | 19.78 | 0.54 | ||||
CVS | 100.0B | 357.8B | 11.97 | 0.28 | ||||
HCA | 87.7B | 65.0B | 16.74 | 1.35 | ||||
CNC | 41.9B | 154.0B | 15.51 | 0.27 | ||||
UHS | 12.6B | 14.3B | 17.56 | 0.88 | ||||
DVA | 12.0B | 12.1B | 17.36 | 0.99 | ||||
MID-CAP | ||||||||
CHE | 9.7B | 2.3B | 35.74 | 4.3 | ||||
ACHC | 7.2B | 2.9B | -333.68 | 2.47 | ||||
AMN | 2.3B | 3.8B | 11.05 | 0.61 | ||||
AMEH | 2.3B | 1.4B | 37.6 | 1.65 | ||||
SMALL-CAP | ||||||||
ADUS | 1.7B | 1.1B | 26.93 | 1.59 | ||||
BKD | 1.2B | 3.0B | -6.6 | 0.41 | ||||
BEAT | 56.3M | - | -3.85 | - | ||||
AMS | 16.9M | 20.7M | 83.48 | 0.82 |
US Physical Therapy Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 3.2% | 155 | 150 | 151 | 149 | 141 | 140 | 141 | 132 | 130 | 126 | 127 | 112 | 117 | 109 | 84.00 | 113 | 122 | 117 | 126 | 116 | 117 |
Gross Profit | 9.3% | 31.00 | 28.00 | 32.00 | 31.00 | 28.00 | 27.00 | 31.00 | 27.00 | 27.00 | 30.00 | 34.00 | 26.00 | 29.00 | 30.00 | 19.00 | 16.00 | 27.00 | 27.00 | 31.00 | 27.00 | 25.00 |
Costs and Expenses | 1.8% | 124 | 122 | 119 | 118 | 113 | 113 | 110 | 105 | 103 | 96.00 | 93.00 | 86.00 | 88.00 | 79.00 | 65.00 | 97.00 | 95.00 | 90.00 | 95.00 | 90.00 | 92.00 |
S&GA Expenses | 15.4% | 14.00 | 12.00 | 12.00 | 14.00 | 12.00 | 12.00 | 11.00 | 12.00 | 11.00 | 13.00 | 12.00 | 11.00 | 11.00 | 10.00 | 9.00 | 12.00 | 12.00 | 11.00 | 12.00 | 11.00 | 10.00 |
EBITDA Margin | -9.6% | 0.12* | 0.13* | 0.13* | 0.13* | 0.14* | 0.16* | 0.16* | 0.17* | 0.17* | 0.19* | 0.20* | 0.21* | - | - | - | - | - | - | - | - | - |
Interest Expenses | -44.2% | 2.00 | 3.00 | 3.00 | 1.00 | 4.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 1.00 | 0.00 | 0.00 | 1.00 | 1.00 | 0.00 | 1.00 |
Income Taxes | -60.7% | 1.00 | 4.00 | 4.00 | 3.00 | 1.00 | 3.00 | 4.00 | 3.00 | 4.00 | 4.00 | 5.00 | 3.00 | 5.00 | 4.00 | 4.00 | 0.00 | 2.00 | 3.00 | 5.00 | 3.00 | 3.00 |
Earnings Before Taxes | -99.3% | 0.00 | 16.00 | 19.00 | 14.00 | 5.00 | 16.00 | 19.00 | 15.00 | 18.00 | 18.00 | 22.00 | 15.00 | 23.00 | 20.00 | 19.00 | 4.00 | 14.00 | 16.00 | 25.00 | 15.00 | 16.00 |
EBT Margin | -10.3% | 0.08* | 0.09* | 0.09* | 0.10* | 0.10* | 0.13* | 0.14* | 0.14* | 0.15* | 0.16* | 0.17* | 0.18* | - | - | - | - | - | - | - | - | - |
Net Income | -92.9% | 1.00 | 9.00 | 11.00 | 7.00 | 3.00 | 10.00 | 11.00 | 9.00 | 10.00 | 10.00 | 12.00 | 8.00 | 13.00 | 11.00 | 10.00 | 1.00 | 8.00 | 9.00 | 15.00 | 8.00 | 10.00 |
Net Income Margin | -8.6% | 0.05* | 0.05* | 0.05* | 0.05* | 0.06* | 0.07* | 0.08* | 0.08* | 0.08* | 0.09* | 0.10* | 0.10* | - | - | - | - | - | - | - | - | - |
Free Cashflow | 64.0% | 27.00 | 16.00 | 27.00 | 11.00 | 17.00 | 14.00 | 16.00 | 12.00 | 16.00 | 25.00 | 18.00 | 18.00 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -1.3% | 997 | 1,010 | 1,000 | 868 | 858 | 800 | 796 | 764 | 749 | 630 | 749 | 749 | 594 | 575 | 585 | 594 | 631 | 561 | 561 | 523 | 443 |
Current Assets | 2.1% | 233 | 228 | 242 | 118 | 111 | 113 | 122 | 96.00 | 95.00 | 79.00 | 80.00 | 76.00 | 88.00 | 83.00 | 92.00 | 149 | 85.00 | 93.00 | 107 | 81.00 | 79.00 |
Cash Equivalents | 3.5% | 153 | 148 | 161 | 33.00 | 32.00 | 38.00 | 49.00 | 24.00 | 29.00 | 19.00 | 20.00 | 18.00 | 33.00 | 30.00 | 44.00 | 90.00 | 24.00 | 28.00 | 35.00 | 20.00 | 23.00 |
Net PPE | 0.1% | 26.00 | 26.00 | 25.00 | 25.00 | 25.00 | 25.00 | 24.00 | 24.00 | 23.00 | 22.00 | 22.00 | 22.00 | 22.00 | 21.00 | 23.00 | 23.00 | 22.00 | 21.00 | 20.00 | 21.00 | 20.00 |
Goodwill | -2.6% | 510 | 523 | 507 | 501 | 494 | 450 | 443 | 444 | 435 | 374 | 374 | 360 | 346 | 337 | 331 | 331 | 318 | 317 | 304 | 293 | 294 |
Liabilities | 0.9% | 345 | 342 | 344 | 384 | 374 | 333 | 336 | 304 | 297 | 201 | 195 | 182 | 184 | 170 | 192 | 260 | 181 | 188 | 193 | 165 | 92.00 |
Current Liabilities | 24.1% | 102 | 82.00 | 86.00 | 91.00 | 85.00 | 81.00 | 85.00 | 89.00 | 83.00 | 82.00 | 75.00 | 91.00 | 93.00 | 93.00 | 87.00 | 71.00 | 61.00 | 63.00 | 57.00 | 69.00 | 42.00 |
LT Debt, Current | 1.8% | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 7.00 | 5.00 | 1.00 | 1.00 | 1.00 | 1.00 | 5.00 | 5.00 | 5.00 | 5.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Shareholder's Equity | -3.2% | 476 | 492 | 490 | 319 | 316 | 319 | 309 | 302 | 297 | 291 | 285 | 277 | 278 | 266 | 257 | 242 | 242 | 237 | 231 | 221 | 217 |
Retained Earnings | -6.2% | 224 | 239 | 238 | 235 | 233 | 236 | 232 | 227 | 224 | 219 | 216 | 210 | 212 | 203 | 195 | 183 | 184 | 181 | 177 | 169 | 167 |
Additional Paid-In Capital | 0.7% | 281 | 279 | 277 | 112 | 110 | 109 | 107 | 105 | 103 | 102 | 99.00 | 97.00 | 96.00 | 93.00 | 91.00 | 90.00 | 87.00 | 86.00 | 84.00 | 82.00 | 80.00 |
Accumulated Depreciation | 0.2% | 85.00 | 85.00 | 84.00 | 82.00 | 80.00 | 79.00 | 77.00 | 77.00 | 75.00 | 74.00 | 72.00 | 70.00 | 69.00 | 68.00 | 67.00 | 67.00 | 66.00 | 65.00 | 64.00 | 65.00 | 64.00 |
Shares Outstanding | -5.3% | 14.00 | 15.00 | 14.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | - | - | - | - | - | - | - | - | - |
Minority Interest | -20.9% | 1.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 2.00 | 1.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 1.00 | 1.00 | 1.00 |
Float | - | - | - | 1,100 | - | - | - | 774 | - | - | - | 838 | - | - | - | 565 | - | - | - | 779 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 64.0% | 26,835 | 16,364 | 27,430 | 11,349 | 17,299 | 13,727 | 15,862 | 11,649 | 15,905 | 24,945 | 17,882 | 17,674 | 25,393 | 26,246 | 31,976 | 16,380 | 15,984 | 17,843 | 15,058 | 13,563 | 19,000 |
Share Based Compensation | -4.0% | 1,785 | 1,859 | 1,786 | 1,806 | 1,802 | 1,802 | 1,814 | 1,846 | 1,587 | 2,875 | 1,754 | 1,651 | 2,592 | 1,936 | 1,503 | 1,886 | 1,723 | 1,704 | 1,830 | 1,728 | 1,486 |
Cashflow From Investing | 50.3% | -8,414 | -16,941 | -6,979 | -12,681 | -43,391 | -14,338 | -7,596 | -15,944 | -79,878 | -10,883 | -20,172 | -13,203 | -28,288 | -4,836 | -2,156 | -15,923 | -6,028 | -6,724 | -20,611 | -4,630 | -2,029 |
Cashflow From Financing | -6.5% | -13,281 | -12,476 | 107,682 | 2,343 | 19,772 | -10,047 | 16,077 | -43.00 | 73,352 | -15,293 | 4,772 | -19,452 | 5,684 | -34,836 | -75,816 | 65,546 | -14,264 | -18,122 | 20,174 | -12,063 | -25,844 |
Dividend Payments | 0% | 6,445 | 6,445 | - | - | 5,331 | 5,331 | 10,659 | - | 4,831 | 4,906 | 9,028 | - | - | - | - | - | 3,832 | 3,832 | - | - | 2,918 |
CONSOLIDATED STATEMENTS OF NET INCOME - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenues: | |||
Net revenue | $ 604,802 | $ 553,144 | $ 495,022 |
Operating cost: | |||
Salaries and related costs | 353,390 | 319,191 | 278,469 |
Rent, supplies, contract labor and other | 123,731 | 116,381 | 94,066 |
Provision for credit losses | 6,172 | 5,548 | 5,305 |
Total operating cost | 483,293 | 441,120 | 377,840 |
Gross profit | 121,509 | 112,024 | 117,182 |
Corporate office costs | 51,953 | 46,111 | 46,533 |
Impairment of goodwill and other intangible assets | 17,495 | 9,112 | 0 |
Operating income | 52,061 | 56,801 | 70,649 |
Other (expense) income | |||
Interest expense, debt and other | (9,303) | (5,779) | (942) |
Interest income from investments | 3,774 | 0 | 0 |
Change in fair value of contingent earn-out consideration | (1,550) | 2,520 | 0 |
Change in revaluation of put-right liability | 2,582 | (5) | 0 |
Equity in earnings of unconsolidated affiliate | 955 | 1,175 | 112 |
Relief funds | 467 | 0 | 4,597 |
Settlement of a legal matter | 0 | 0 | (2,635) |
Resolution of a payor matter | 0 | 0 | 1,216 |
Other | 390 | 859 | 199 |
Total other (expense) income | (2,685) | (1,230) | 2,547 |
Income before taxes | 49,376 | 55,571 | 73,196 |
Provision for income taxes | 12,156 | 12,164 | 15,272 |
Net income | 37,220 | 43,407 | 57,924 |
Less: Net income attributable to non-controlling interest: | |||
Redeemable non-controlling interest - temporary equity | (4,426) | (6,902) | (11,358) |
Non-controlling interest - permanent equity | (4,555) | (4,347) | (5,735) |
Net income attributable to non-controlling interest | (8,981) | (11,249) | (17,093) |
Net income attributable to USPH shareholders | $ 28,239 | $ 32,158 | $ 40,831 |
Basic earnings per share attributable to USPH shareholders (in dollars per share) | $ 1.28 | $ 2.25 | $ 2.41 |
Diluted earnings per share attributable to USPH shareholders (in dollars per share) | $ 1.28 | $ 2.25 | $ 2.41 |
Shares used in computation - basic (in shares) | 14,188 | 12,985 | 12,898 |
Shares used in computation - diluted (in shares) | 14,188 | 12,985 | 12,898 |
Dividends declared per common share (in dollars per share) | $ 1.72 | $ 1.64 | $ 1.46 |
Net Patient Revenue [Member] | |||
Revenues: | |||
Net revenue | $ 514,556 | $ 464,590 | $ 438,330 |
Other Revenue [Member] | |||
Revenues: | |||
Net revenue | $ 90,246 | $ 88,554 | $ 56,692 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 152,825 | $ 31,594 |
Patient accounts receivable, less provision for credit losses of $2,736 and $2,829, respectively | 51,866 | 51,934 |
Accounts receivable - other | 17,854 | 16,671 |
Other current assets | 10,830 | 11,067 |
Total current assets | 233,375 | 111,266 |
Fixed assets: | ||
Furniture and equipment | 63,982 | 62,074 |
Leasehold improvements | 46,941 | 42,877 |
Fixed assets, gross | 110,923 | 104,951 |
Less accumulated depreciation and amortization | (84,821) | (80,203) |
Fixed assets, net | 26,102 | 24,748 |
Operating lease right-of-use assets | 103,431 | 103,004 |
Investment in unconsolidated affiliate | 12,256 | 12,131 |
Goodwill | 509,571 | 494,101 |
Other identifiable intangible assets, net | 109,682 | 108,755 |
Other assets | 2,821 | 4,149 |
Total assets | 997,238 | 858,154 |
Current liabilities: | ||
Accounts payable - trade | 3,898 | 3,300 |
Accounts payable - due to seller of acquired business | 0 | 3,204 |
Accrued expenses | 55,344 | 37,413 |
Current portion of operating lease liabilities | 35,252 | 33,709 |
Current portion of term loan and notes payable | 7,691 | 7,863 |
Total current liabilities | 102,185 | 85,489 |
Notes payable, net of current portion | 1,289 | 1,913 |
Revolving facility | 0 | 31,000 |
Term loan, net of current portion and deferred financing costs | 137,702 | 142,918 |
Deferred taxes | 24,815 | 21,303 |
Operating lease liabilities, net of current portion | 76,653 | 77,934 |
Other long-term liabilities | 2,356 | 13,029 |
Total liabilities | 345,000 | 373,586 |
Redeemable non-controlling interest - temporary equity | 174,828 | 167,515 |
Commitments and Contingencies | ||
U.S. Physical Therapy, Inc. ("USPH") shareholders' equity: | ||
Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding | 0 | 0 |
Common stock, $.01 par value, 20,000,000 shares authorized, 17,202,291 and 15,216,326 shares issued, respectively | 172 | 152 |
Additional paid-in capital | 281,096 | 110,317 |
Accumulated other comprehensive gain | 2,782 | 4,004 |
Retained earnings | 223,772 | 232,948 |
Treasury stock at cost, 2,214,737 shares | (31,628) | (31,628) |
Total USPH shareholders' equity | 476,194 | 315,793 |
Non-controlling interest - permanent equity | 1,216 | 1,260 |
Total USPH shareholders' equity and non-controlling interest - permanent equity | 477,410 | 317,053 |
Total liabilities, redeemable non-controlling interest, USPH shareholders' equity and non-controlling interest - permanent equity | $ 997,238 | $ 858,154 |